Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Int J Cardiovasc Imaging. 2019 Nov;35(11):2095-2102. doi: 10.1007/s10554-019-01659-w. Epub 2019 Jul 3.
Cardiac magnetic resonance-tissue tracking (CMR-TT)-derived myocardial strain after ST-elevation myocardial infarction (STEMI) is related to adverse cardiac events. We aimed to investigate the feasibility of CMR-TT for the early prediction of adverse left ventricular (LV) remodeling after STEMI. We retrospectively searched our institution's STEMI registry for patients who underwent reperfusion therapy, post-reperfusion CMR within 1 week after STEMI, and follow-up CMR. CMR-TT analysis was performed using cine imaging of post-reperfusion CMR. Adverse LV remodeling was defined as an increase in end-diastolic LV volume by 20% or more on follow-up CMR (median interval between serial CMR exams, 197 days; interquartile, 174-241 days). A total of 82 patients (age, 59.2 ± 11.1 years; male:female = 73:9) were included and divided into two groups: STEMI without (n = 62) and with (n = 20) adverse LV remodeling. Patients with LV remodeling showed significantly higher peak creatine kinase-MB and troponin I levels and a larger infarct size compared with those without LV remodeling (p = 0.001, p = 0.001, and p = 0.010, respectively). Global circumferential, radial, and longitudinal strain (GLS) also differed significantly between the groups (p = 0.001, p = 0.004, and p < 0.001, respectively). Logistic regression and receiver operating characteristic curve analyses demonstrated that GLS was an independent predictor of LV remodeling [odds ratio (OR) = 1.282, 95% confidence interval (CI) = 1.060-1.55 p = 0.011] with an optimal cut-off of - 12.84 (AUC = 0.756, 95% CI = 0.636-0.887, p < 0.001). CMR-TT-derived GLS may aid the early prediction of adverse LV remodeling after reperfusion, within 1 week after STEMI.
心肌梗死后 ST 段抬高(STEMI)患者的心脏磁共振组织追踪(CMR-TT)衍生心肌应变与不良心脏事件相关。我们旨在研究 CMR-TT 用于预测 STEMI 后早期不良左心室(LV)重构的可行性。我们回顾性地在我们机构的 STEMI 注册处搜索了接受再灌注治疗、STEMI 后 1 周内行再灌注 CMR 检查和随访 CMR 的患者。CMR-TT 分析采用再灌注 CMR 的电影成像进行。不良 LV 重构定义为随访 CMR 时 LV 舒张末期容积增加 20%或更多(两次连续 CMR 检查之间的中位数间隔时间为 197 天;四分位距为 174-241 天)。共纳入 82 例患者(年龄 59.2±11.1 岁;男性:女性=73:9),分为两组:无不良 LV 重构组(n=62)和有不良 LV 重构组(n=20)。与无 LV 重构组相比,LV 重构患者的肌酸激酶同工酶-MB 和肌钙蛋白 I 峰值水平显著更高,梗死面积也更大(p=0.001、p=0.001 和 p=0.010)。两组之间的整体周向、径向和纵向应变(GLS)也存在显著差异(p=0.001、p=0.004 和 p<0.001)。Logistic 回归和受试者工作特征曲线分析表明,GLS 是 LV 重构的独立预测因子[比值比(OR)=1.282,95%置信区间(CI)=1.060-1.55,p=0.011],最佳截断值为-12.84(AUC=0.756,95%CI=0.636-0.887,p<0.001)。CMR-TT 衍生的 GLS 可能有助于在 STEMI 后 1 周内预测再灌注后不良 LV 重构。